Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 8,182 shares at $34.17 ($280K) on 2025-07-01, disclosed to the SEC on 2025-07-03.
Scheduled sale ($280k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.17 | 4,091 | $140K | 50.0% |
| 2 | $34.17 | 4,091 | $140K | 50.0% |
| Total | $34.17 avg | 8,182 | $280K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |